Angiopoietin-1, but not Platelet-Derived Growth Factor-AB, Is a Cooperative Stimulator of Vascular Endothelial Growth Factor A-Accelerated Endothelial Cell Scratch Closure

Annals of Vascular Surgery

Volumn 23, Issue 2, 2009, Pages 239-245

  Alter, Alexander ^a   Schmiedeck, Dorothee ^a   Fussnegger, Markus R ^a   Pries, Axel R ^a   Freesmeyer, Wolfgang B ^a   Zakrzewicz, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; PLATELET DERIVED GROWTH FACTOR AB; VASCULOTROPIN 165; VASCULOTROPIN A;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN; WOUND CLOSURE;

ANGIOPOIETIN-1; ANGIOPOIETIN-2; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; PLATELET-DERIVED GROWTH FACTOR; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 62249180042     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2008.07.010     Document Type: Article

References (44)

1. Velazquez O.C. Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing. J Vasc Surg 45 Suppl. A (2007) A39-A47
2. Eming S.A., Brachvogel B., Odorisio T., et al. Regulation of angiogenesis: wound healing as a model. Prog. Histochem. Cytochem 42 (2007) 115-170
3. Nakanishi Y., Izumi K., Yoshizawa M., et al. The expression and production of vascular endothelial growth factor in oral mucosa equivalents. Int J Oral Maxillofac. Surg 36 (2007) 928-933
4. Nissen N.N., Polverini P.J., Koch A.E., et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 152 (1998) 1445-1452
5. Bell G.W., Large D.M., and Barclay S.C. Oral health care in diabetes mellitus. SADJ 55 (2000) 158-165
6. Lehr H.A. Microcirculatory dysfunction induced by cigarette smoking. Microcirculation 7 (2000) 367-384
7. Martin A., Komada M.R., and Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23 (2003) 117-145
8. Mellado-Valero A., Ferrer Garcia J.C., Herrera Ballester A., et al. Effects of diabetes on the osseointegration of dental implants. Med Oral Patol Oral Cir Bucal 12 (2007) E38-E43
9. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25 (2004) 581-611
10. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
11. Anitua E., Andia I., Ardanza B., et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost 91 (2004) 4-15
12. D'Amore P.A., and Smith S.R. Growth factor effects on cells of the vascular wall: a survey. Growth Factors 8 (1993) 61-75
13. Hoffmann J., Feng Y., vom Hagen F., et al. Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J 19 (2005) 2035-2036
14. Asahara T., Chen D., Takahashi T., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83 (1998) 233-240
15. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997) 55-60
16. Detmar M., Brown L.F., Schon M.P., et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111 (1998) 1-6
17. Dvorak H.F., Brown L.F., Detmar M., et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
18. Hobbs S.K., Monsky W.L., Yuan F., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95 (1998) 4607-4612
19. Monsky W.L., Fukumura D., Gohongi T., et al. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor. Cancer Res 59 (1999) 4129-4135
20. Roberts W.G., and Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108 (1995) 2369-2379
21. Hao X., Mansson-Broberg A., Blomberg P., et al. Angiogenic and cardiac functional effects of dual gene transfer of VEGF-A165 and PDGF-BB after myocardial infarction. Biochem Biophys Res Commun 322 (2004) 292-296
22. Richardson T.P., Peters M.C., Ennett A.B., et al. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 (2001) 1029-1034
23. Benest A.V., Salmon A.H., Wang W., et al. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue. Microcirculation 13 (2006) 423-437
24. Chae J.K., Kim I., Lim S.T., et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20 (2000) 2573-2578
25. 165/angiopoietin-1 gene and endothelial progenitor cells for therapeutic neovascularization. Eur J Pharmacol 568 (2007) 222-230
26. Yamauchi A., Ito Y., Morikawa M., et al. Pre-administration of angiopoietin-1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model. J Gene Med 5 (2003) 994-1004
27. Bongrazio M., Da Silva-Azevedo L., Bergmann E.C., et al. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo. Int J Immunopathol Pharmacol 19 (2006) 35-48
28. Breier G., and Risau W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol 6 (1996) 454-456
29. Walsh D.A. Pathophysiological mechanisms of angiogenesis. Adv Clin Chem. 44 (2007) 187-221
30. Lee S., Chen T.T., Barber C.L., et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130 (2007) 691-703
31. Zacchigna S., Tasciotti E., Kusmic C., et al. In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature. Hum Gene Ther 18 (2007) 515-524
32. Lindahl P., Johansson B.R., Leveen P., et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997) 242-245
33. Chen R.R., Silva E.A., Yuen W.W., et al. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24 (2007) 258-264
34. Jones N., Master Z., Jones J., et al. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274 (1999) 30896-30905
35. DeBusk L.M., Hallahan D.E., and Lin P.C. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 298 (2004) 167-177
36. Thurston G., Suri C., Smith K., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
37. Witzenbichler B., Westermann D., Knueppel S., et al. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111 (2005) 97-105
38. Cornelini R., Artese L., Rubini C., et al. Vascular endothelial growth factor and microvessel density around healthy and failing dental implants. Int J Oral MaxillofacImplants 16 (2001) 389-393
39. Jain R.K., and Munn L.L. Leaky vessels? Call Ang1!. Nat. Med 6 (2000) 131-132
40. Mandriota S.J., and Pepper M.S. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83 (1998) 852-859
41. Fiedler U., Reiss Y., Scharpfenecker M., et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12 (2006) 235-239
42. Daly C., Pasnikowski E., Burova E., et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 103 (2006) 15491-15496
43. Chlench S., Mecha Disassa N., Hohberg M., et al. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett 581 (2007) 673-680
44. Zymek P., Bujak M., Chatila K., et al. The role of platelet-derived growth factor signaling in healing myocardial infarcts. J Am Coll Cardiol 48 (2006) 2315-2323